Microbial Natural Products Yield Promising Dual Drug Candidates for Diabetes and Liver Disease
Two of the world’s fastest-growing metabolic epidemics—type 2 diabetes mellitus and metabolic dysfunction-associated steatohepatitis, better known as MASH—have long been...




















